AI Assistant
Blog
Pricing
Log In
Sign Up
Meilenstein in der Therapie des Typ-2-Diabetes – Kardiovaskuläre Risikoreduktion in EMPA-REG OUTCOME®-Studie gezeigt
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.
